Molecular targets of statins and their potential side effects: Not all the glitter is gold

KK Patel, VS Sehgal, K Kashfi - European journal of pharmacology, 2022 - Elsevier
Statins are a class of drugs widely used worldwide to manage hypercholesterolemia and the
prevention of secondary heart attacks. Currently, available statins vary in terms of their …

Statins in cancer prevention and therapy

N Ricco, SJ Kron - Cancers, 2023 - mdpi.com
Simple Summary Retrospective studies of common malignancies such as head and neck
cancer often report lower incidence and/or better outcomes for patients incidentally treated …

Regulation of PD-L1 through direct binding of cholesterol to CRAC motifs

Q Wang, Y Cao, L Shen, T Xiao, R Cao, S Wei… - Science …, 2022 - science.org
Cholesterol, an essential molecule for cell structure, function, and viability, plays crucial
roles in the development, progression, and survival of cancer cells. Earlier studies have …

Atorvastatin enhances the efficacy of immune checkpoint therapy and suppresses the cellular and extracellular vesicle PD-L1

EJ Choe, CH Lee, JH Bae, JM Park, SS Park, MC Baek - Pharmaceutics, 2022 - mdpi.com
According to clinical studies, statins improve the efficacy of programmed death-
1/programmed death-ligand 1 (PD-1/PD-L1) blockade therapy for breast cancer; however …

[HTML][HTML] Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune suppression by downregulating PD …

N Uemura, H Hayashi, Z Liu, K Matsumura… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Statins are cholesterol-lowering agents that act as inhibitors of 3-hydroxy-3-methyl-glutaryl-
coenzymeA (HMG CoA) reductase. Recently, statins have received a lot of attention …

[HTML][HTML] Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment

K Laubach, T Turan, R Mathew… - Cancer Drug …, 2023 - ncbi.nlm.nih.gov
The development of immune checkpoint blockade (ICB) therapies has been instrumental in
advancing the field of immunotherapy. Despite the prominence of these treatments, many …

B7 family protein glycosylation: promising novel targets in tumor treatment

L Xiao, X Guan, M Xiang, Q Wang, Q Long… - Frontiers in …, 2022 - frontiersin.org
Cancer immunotherapy, including the inhibition of immune checkpoints, improves the tumor
immune microenvironment and is an effective tool for cancer therapy. More effective and …

Effect of statins on lung cancer molecular pathways: A possible therapeutic role

G Marcianò, C Palleria, A Casarella, V Rania, E Basile… - Pharmaceuticals, 2022 - mdpi.com
Lung cancer is a common neoplasm, usually treated through chemotherapy, radiotherapy
and/or surgery. Both clinical and experimental studies on cancer cells suggest that some …

Comedications with immune checkpoint inhibitors: involvement of the microbiota, impact on efficacy and practical implications

J Colard-Thomas, QD Thomas, M Viala - Cancers, 2023 - mdpi.com
Simple Summary Since the approval of immune checkpoint inhibitors for solid tumors,
concerns have been raised about the role of the microbiota on immunotherapy success and …

Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin

P Efentakis, A Choustoulaki, G Kwiatkowski… - Basic Research in …, 2024 - Springer
Immune checkpoint inhibitors (ICIs) exhibit remarkable antitumor activity and immune-
related cardiotoxicity of unknown pathomechanism. The aim of the study was to investigate …